Feb 8, 2023
Curio Bioscience on Wednesday emerged from stealth mode, saying it has commenced commercial operations with the launch of Curio Seeker, a high-resolution, whole-transcriptome spatial mapping kit.
Leveraging the Slide-seq technique that its academic co-founders created at the Broad Institute of MIT and Harvard, Curio Seeker enables laboratories to generate whole-transcriptome spatial data from tissue samples in an easy-to-use workflow, the firm said.
“We have known for years that the spatial mapping of tissue has the potential to accelerate novel discoveries and advance our understanding of human biology,” Steve Fodor, co-founder and CEO of Curio Bioscience, said in a statement.
Curio Seeker enables life science researchers to access high-resolution transcriptomics information in their organism of choice, he said, adding, “We believe that Curio Seeker will take discovery beyond what is possible with current single-cell sequencing approaches and establish a new industry standard for spatial transcriptomics.”
Curio’s academic co-founders are Dr. Evan Macosko, associate professor of psychiatry at Massachusetts General Hospital and an institute member at the Broad; Dr. Fei Chen, assistant professor at the Harvard Department of Stem Cell and Regenerative Biology and a core institute member at the Broad; and Dr. Samuel Rodriques, group leader at the Francis Crick Institute.
